Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Mizumoto, Masashi ^a,b   Sugahara, Shinji ^a,b,c   Okumura, Toshiyuki ^a,b   Hashimoto, Takayuki ^a,b   Oshiro, Yoshiko ^a,b   Fukumitsu, Nobuyoshi ^a,b   Nakahara, Akira ^b   Terashima, Hideo ^b   Tsuboi, Koji ^a,b   Sakurai, Hideyuki ^a,b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Hyperfractionated; Proton beam therapy; Radiotherapy; Toxicity

Indexed keywords

COMPLETE RESPONSE; ESOPHAGEAL CANCER; ESOPHAGEAL CARCINOMA; ESOPHAGITIS; HEMATOLOGIC TOXICITY; HYPERFRACTIONATED; LOCAL CONTROL; MEDIAN SURVIVAL; NONHEMATOLOGIC TOXICITY; PARTIAL RESPONSE; PROTON BEAM THERAPY; RADIATION-INDUCED; RESPONSE RATE; SURVIVAL RATE; TOTAL DOSE; TREATMENT INTERRUPTION;

DISEASES; PROTON BEAMS; PROTONS; TOXICITY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ESOPHAGITIS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTONS; SURVIVAL RATE;

EID: 80155157634     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.041     Document Type: Article

References (28)

1. M. Kenjo, T. Uno, and Y. Murakami Radiation therapy for esophageal cancer in Japan: Results of the Patterns of Care Study 1999-2001 Int J Radiat Oncol Biol Phys 75 2009 357 363
2. S. Ishikura, K. Nihei, and A. Ohtsu Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus J Clin Oncol 21 2003 2697 2702 (Pubitemid 46606313)
3. S. Sugahara, K. Tokuuye, and T. Okumura Clinical results of proton beam therapy for cancer of the esophagus Int J Radiat Oncol Biol Phys 61 2005 76 84 (Pubitemid 40039108)
4. M. Mizumoto, S. Sugahara, and H. Nakayama Clinical results of proton beam therapy for locoregionally advanced esophageal cancer Strahlenther Onkol 186 2010 482 488
5. X. Zhang, K.L. Zhao, and T.M. Guerrero Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer Int J Radiat Oncol Biol Phys 72 2008 278 287
6. C. Wang, H. Nakayama, and S. Sugahara Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer Strahlenther Onkol 185 2009 231 234
7. O.K. Macdonald, J.J. Kruse, and J.M. Miller Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: A comparative dosimetric analysis Int J Radiat Oncol Biol Phys 75 2009 950 958
8. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis Lancet 368 2006 843 854 (Pubitemid 44292807)
9. P. Jenkins, S. Anderson, and S. Wronski A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer Radiother Oncol 93 2009 396 401
10. K.L. Zhao, X.H. Shi, and G.L. Jiang Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: A phase III randomized study Int J Radiat Oncol Biol Phys 62 2005 1014 1020
11. K.L. Zhao, X.H. Shi, and G.L. Jiang Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma Int J Radiat Oncol Biol Phys 60 2004 123 129
12. M. Mizumoto, K. Tsuboi, and H. Igaki Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme Int J Radiat Oncol Biol Phys 77 2010 98 105
13. K. Sugimachi, S. Ohno, and H. Matsuda Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus Ann Surg 208 1988 179 183
14. Y. Tsunashima, T. Sakae, and Y. Shioyama Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy Int J Radiat Oncol Biol Phys 60 2004 951 958 (Pubitemid 39311777)
15. H. Paganetti, A. Niemierko, and M. Ancukiewicz Relative biological effectiveness (RBE) values for proton beam therapy Int J Radiat Oncol Biol Phys 53 2002 407 421 (Pubitemid 34522107)
16. L.E. Gerweck, and S.V. Kozin Relative biological effectiveness of proton beams in clinical therapy Radiother Oncol 50 1999 135 142 (Pubitemid 29155537)
17. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181 (Pubitemid 36962641)
18. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
19. S. Sugahara, Y. Oshiro, and H. Nakayama Proton beam therapy for large hepatocellular carcinoma Int J Radiat Oncol Biol Phys 76 2010 460 466
20. M. Mizumoto, K. Tokuuye, and S. Sugahara Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis Int J Radiat Oncol Biol Phys 71 2008 462 467
21. M. Mizumoto, K. Tokuuye, and S. Sugahara Proton beam therapy for hepatocellular carcinoma with inferior vena cava tumor thrombus: Report of three cases Jpn J Clin Oncol 37 2007 459 462 (Pubitemid 47249484)
22. H. Nakayama, S. Sugahara, and M. Tokita Proton beam therapy for hepatocellular carcinoma: The University of Tsukuba experience Cancer 115 2009 5499 5506
23. Mizumoto M, Okumura T, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols. Int J Radiat Oncol Biol Phys. In press.
24. H. Nakayama, S. Sugahara, and M. Tokita Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the University of Tsukuba Int J Radiat Oncol Biol Phys 78 2010 467 471
25. H.D. Thames Jr, H.R. Withers, and L.J. Peters Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships Int J Radiat Oncol Biol Phys 8 1982 219 226 (Pubitemid 12139897)
26. H.R. Withers Biologic basis for altered fractionation schemes Cancer 55 1985 2086 2095 (Pubitemid 15077682)
27. A. Herskovic, K. Martz, and M. al-Sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
28. J.S. Cooper, M.D. Guo, and A. Herskovic Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1999 1623 1627 (Pubitemid 29211772)